Oral Iron for Chronic Kidney Disease
(FeTCh-CKD Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot have had iron therapy or certain blood treatments in the last 3-4 months before joining.
What data supports the effectiveness of the drug Ferrous Sulfate for chronic kidney disease?
The research indicates that oral iron, like Ferrous Sulfate, is commonly used to treat iron deficiency anemia in chronic kidney disease patients. Although the study did not find a significant difference in kidney function decline between oral and intravenous iron, oral iron was associated with fewer serious adverse events compared to intravenous iron.12345
Is oral iron, like ferrous sulfate, safe for people with chronic kidney disease?
How does the drug Ferrous Sulfate differ from other treatments for chronic kidney disease?
What is the purpose of this trial?
This trial tests iron pills in children with kidney disease and mild anemia. It aims to see if taking iron improves their muscle strength, activity levels, and eating habits. The study compares children taking iron pills to those who do not over a few months.
Research Team
Oleh Akchurin, M.D.
Principal Investigator
Weill Cornell College of Medicine
Eligibility Criteria
This trial is for children aged 1-21 with chronic kidney disease and mild anemia, not on hemodialysis or expecting a transplant soon. They must have specific levels of kidney function, hemoglobin, transferrin saturation, and serum ferritin to join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into a standard of care (iron sulfate) arm vs. no iron therapy arm for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Ferrous Sulfate
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
Children's Hospital of Philadelphia
Collaborator